Header cover image

Swiss Pharmaceuticals & Biotech Stable Growth Stocks

Results

2

0 new

2 companies

Galderma Group

Market Cap: CHF 40.5b

Operates as a dermatology company worldwide.

GALD

CHF 172.40

7D

0.1%

1Y

53.8%

Bachem Holding

Market Cap: CHF 5.0b

Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.

BANB

CHF 67.95

7D

2.9%

1Y

16.6%